PT - JOURNAL ARTICLE AU - Shana AB Burrowes AU - Olga Goloubeva AU - Kristen Stafford AU - Patrick F. McArdle AU - Madhav Goyal AU - B. Lee Peterlin AU - Jennifer A. Haythornthwaite AU - David A. Seminowicz TI - Effects Of Mindfulness On Sleep Quality, Anxiety, Depression and Stress In Migraine AID - 10.1101/2020.07.20.20158212 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.20.20158212 4099 - http://medrxiv.org/content/early/2020/07/25/2020.07.20.20158212.short 4100 - http://medrxiv.org/content/early/2020/07/25/2020.07.20.20158212.full AB - Objective To examine the change over time in sleep quality and psychosocial outcomes from the MRI Outcomes for Mindfulness Meditation Clinical Trial, assess how these mediated treatment response (50% reduction in headache frequency post-intervention) and examine the relationship between baseline values and treatment response.Methods This is a secondary analysis of a randomized placebo-controlled trial with single masking. Patients were recruited from the community, headache clinics and primary care offices in Baltimore Maryland. Eligible patients were aged 18-65 and met the International Classification of Headache Disorders criteria for episodic migraine (4-14 headache days in 28 days).The trial (primary outcomes previously reported) included 98 episodic migraine patients randomized to either enhanced (MBSR+) or stress management for headache (SMH). Follow-up visits occurred at 10, 20 and 52 weeks post baseline. Intervention groups met separately for two hours weekly for 8 weeks and then biweekly for an additional 8 weeks. MBSR+ had an additional half-day retreat held between weeks 6 and 8.Results There was a significant improvement in sleep quality from baseline to post-intervention (p=0.0025), in both groups. There were no significant change from baseline or between groups in anxiety, depression and stress. There was also no significant association between baseline scores and treatment response. Mediation analysis showed a significant indirect effect for sleep, anxiety, stress, and depression on treatment response, ranging from 6-8%.Conclusions The findings indicate that in episodic migraine, treatment response to MBSR+ compared to SMH was mediated by small, but significant improvements in sleep, anxiety, stress, and depression.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02133209Funding StatementSupported by NCCIH/NIH R01 AT007176 to DAS. Authors nor their institutions did not receive payment or services from a third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Johns Hopkins School of Medicine and University of Maryland Baltimore Institutional Review Boards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request.